SAN DIEGO — A fragment antibody against thymic stromal lymphopoietin was safe and effective in reducing airway inflammation among patients with asthma, according to a presentation at the American Thoracic Society International Conference.“Thymic stromal lymphopoietin (TSLP) is involved in chronic inflammatory disorders, including asthma and COPD,” Maria Belvisi, PhD, senior vice
A radioactive tracer developed by Astra Zeneca and the Karolinska Institutet may play a major role for patients with Crohn s disease. That is the belief of Maria Belvisi at AstraZeneca.
AstraZeneca links up with Qureight on lung disease research pharmatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmatimes.com Daily Mail and Mail on Sunday newspapers.
Why patient cohorts are vital for respiratory research astrazeneca.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from astrazeneca.com Daily Mail and Mail on Sunday newspapers.
Second novel target for idiopathic pulmonary fibrosis was discovered using BenevolentAI's drug discovery platform and selected for AstraZeneca's drug development portfolioA total of three targets